2 results match your criteria: "China Union Hospital[Affiliation]"
Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling.
Clin Cancer Res
March 2016
Department of Urology, Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Purpose: Flightless I (FLII), member of the gelsolin superfamily of actin-remodeling proteins, functions as a transcriptional coregulator. We aim to evaluate a tumor-suppressive function of FLII in regulating androgen receptor (AR) in prostate cancer progression.
Experimental Design: We examined FLII protein and mRNA expression in clinical prostate cancer specimens by immunohistochemistry.
[Clinical factors influencing the uses of cortisone in severe acute respiratory syndrome].
Zhonghua Yi Xue Za Zhi
July 2004
Department of Clinical Epidemiology, Fuwai Cardiological Hospital, Chinese Medical Academy, China Union Hospital, Beijing 100037, China